Chong Yu to Clinical Trials as Topic
This is a "connection" page, showing publications Chong Yu has written about Clinical Trials as Topic.
Connection Strength
0.011
-
Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors. J Formos Med Assoc. 2018 Apr; 117(4):326-331.
Score: 0.011